Interfering with pH regulation in tumours as a therapeutic strategy

  • Neri D
  • Supuran C
  • 257

    Readers

    Mendeley users who have this article in their library.
  • 682

    Citations

    Citations of this article.

Abstract

The high metabolic rate of tumours often leads to acidosis and hypoxia in poorly perfused regions. Tumour cells have thus evolved the ability to function in a more acidic environment than normal cells. Key pH regulators in tumour cells include: isoforms 2, 9 and 12 of carbonic anhydrase, isoforms of anion exchangers, Na+/HCO3- co-transporters, Na+/H+ exchangers, monocarboxylate transporters and the vacuolar ATPase. Both small molecules and antibodies targeting these pH regulators are currently at various stages of clinical development. These antitumour mechanisms are not exploited by the classical cancer drugs and therefore represent a new anticancer drug discovery strategy.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Authors

  • Dario Neri

  • Claudiu T. Supuran

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free